Error message
Notice: Undefined index: content in _drupal_default_html_head() (line 345 of /var/www/vhosts/rovi.es/httpdocs/includes/common.inc).
|
Date |
Title |
Description |
PDF |
|
08 May 2024 |
On P&L |
The Company releases the first three months 2024 financial results presentation
|
Download |
|
25 Apr 2024 |
On business and financial situation |
ROVI announces agreement to manufacture pre-filled syringes
|
Download |
|
27 Feb 2024 |
On P&L |
The Company releases the press release related to the full year 2023 financial results.
|
Download |
|
27 Feb 2024 |
On P&L |
The Company releases the full year 2023 financial results presentation.
|
Download |
|
27 Feb 2024 |
About Corporate Governance |
The Company informs about the agreements adopted by the Board of Directors
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
01 Sep 2023 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 25 August and 31 August 2023
|
Download |
|
25 Aug 2023 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 18 August and 24 August 2023
|
Download |
|
18 Aug 2023 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 11 August and 17 August 2023
|
Download |
|
11 Aug 2023 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 3 August and 10 August 2023
|
Download |
|
03 Aug 2023 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 26 July 2023 and 2 August 2023
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
06 Apr 2017 |
Contratos de liquidez y contrapartida |
Liquidity contract: transactions conducted in the first quarter of 2017
|
Download |
|
13 Mar 2017 |
Otros sobre negocio y situación financiera |
The Company releases the presentation related to its biosimilar of Enoxaparin
|
Download |
|
07 Mar 2017 |
Otros sobre negocio y situación financiera |
ROVI informs that the Decentralised procedure used for the registration of its biosimilar of enoxaparin has been completed with positive outcome
|
Download |
|
16 Feb 2017 |
Otros sobre Gobierno Corporativo |
The Company informs about the agreements adopted by the Board of Directors
|
Download |
|
16 Feb 2017 |
Informe anual de remuneraciones de los consejeros |
ROVI releases the 2016 annual report regarding remuneration of the members of the Board of Directors
|
Download |
Pages
